From iPSC engineering to high-resolution genomics. We build the tools you need to discover the next breakthrough.
A future where healthcare is guided by the uniqueness of patients, enabling more effective drug development and personalized care.
To engineer the iPSC models and single-cell genomics tools that turn patient-specific biology into discovery — automated, validated end-to-end, and delivered ready to use.
From iPSC reprogramming to high-resolution genomics, we deliver validated tools for human disease research.
Patient-specific models, CRISPR editing, and automated reprogramming.
View details →Physiologically relevant models for drug testing and barrier studies.
View details →Bulk, single-cell, and long-read RNA sequencing solutions.
View details →scWGS, structural variant detection, and bespoke DNA analysis.
View details →Not on the list? Don't see your application? We build bespoke workflows for emerging research questions. Talk to our team →
Bias-minimized, high-throughput, reproducible.
In-house protocols & the Aneufinder algorithm.
From sample to insight, with you throughout.
We accept PBMCs, dermal fibroblasts, and urine-derived epithelial cells (UDEs), either fresh or cryopreserved. We can advise on the best option for your project.
A standard reprogramming run takes approximately 8-12 weeks from sample receipt to delivery of characterized, quality-controlled iPSC lines.
Yes. Every sequencing project includes a full bioinformatics pipeline — from raw data QC through to publication-ready figures and interpretation.
Absolutely. We routinely handle clinical samples under appropriate ethical approvals and can advise on sample collection, storage, and shipping protocols.
Tell us about your project and we'll bring patient-specific models and high-resolution genomics to your lab.
